Skip to main content
. 2016 May 6;5(6):548–551. doi: 10.1002/cpdd.262

Figure 2.

Figure 2

The human blood plasma tissue factor pathway inhibitor (TFPI) concentration peaked 2 hours after the start of the defibrotide (DF) treatment. Plasma TFPI levels were determined in DF‐treated (infusion over 2 hours) healthy male Japanese subjects. Data represent mean ± standard deviation (SD); n = 4–8 subjects per group. *P < .05 compared with placebo.